Company Data
Akero Therapeutics Inc.
Ticker
AKRO
Current Price
$47.725 5.31%
Market Cap
$3.8B
Price Target
Refer to Report
Volume
928.8K
52wk Range
$17.86 - $58.4
Overview
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis, or NASH, a disease without any approved therapies. The company’s product candidate efruxifermin is an FGF21 analog with properties that has the potential to address the core processes underlying NASH pathogenesis.